Daniel Götz

Title: The Innovative Contributions of Daniel Götz

Introduction

Daniel Götz is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of important compounds. His work has led to advancements that benefit both the scientific community and the pharmaceutical industry.

Latest Patents

Daniel Götz holds a patent for the "Synthesis of copanlisib and its dihydrochloride salt." This invention relates to a novel method of preparing copanlisib, copanlisib dihydrochloride, or hydrates of copanlisib dihydrochloride. It also includes novel intermediate compounds and their use in the preparation of these compounds. The patent highlights the importance of copanlisib dihydrochloride hydrates as valuable compounds in medical applications. He has 1 patent to his name.

Career Highlights

Throughout his career, Daniel Götz has worked with prominent companies in the pharmaceutical sector. He has been associated with Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft, where he has contributed to various innovative projects. His expertise in synthesis and compound development has been instrumental in advancing research and product development.

Collaborations

Daniel Götz has collaborated with several professionals in his field, including Jan-Georg Peters and Philipp Rubenbauer. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective projects.

Conclusion

Daniel Götz's contributions to the field of pharmaceuticals through his innovative patent and collaborations with industry professionals highlight his importance as an inventor. His work continues to influence the development of new medical compounds and methods.